首页> 外文期刊>Chemistry Select >Synthesis of Quinoline-Thiazolidine-2,4-dione Coupled Pyrazoles as in vitro EGFR Targeting Anti-Breast Cancer Agents and Their in silico Studies
【24h】

Synthesis of Quinoline-Thiazolidine-2,4-dione Coupled Pyrazoles as in vitro EGFR Targeting Anti-Breast Cancer Agents and Their in silico Studies

机译:Synthesis of Quinoline-Thiazolidine-2,4-dione Coupled Pyrazoles as in vitro EGFR Targeting Anti-Breast Cancer Agents and Their in silico Studies

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis of some new quinoline-thiazolidine-2,4-dione coupled pyrazoles (7a-7n) via Knoevengal condensation, N-alkynylation and tandem one-pot Sonogashira coupling-cyclo-condensation paths was described. All the compounds were further evaluated for their in vitro anti-breast cancer activity against MDA-MB-231 and MCF-7 and results were compared with standard drug erlotinib. Most of analogues were potent against MCF-7 than the MDA-MB-231. In specific, compounds (Z)-3-((3-(4-methoxyphenyl)-1H-pyrazol-5-yl)methyl)-5-(quino-lin-4-ylmethylene) thiazolidine-2,4-dione (7d) and (Z)-5-(5-((2,4-dioxo-5-(quinolin-4-ylmethylene)thiazolidin-3-yl)methyl)-1H-pyrazol-3-yl)isophthalonitrile (7 m) had superior potency against MCF-7 and MDA-MB-231 with IC_(50) (μg/mL) values ranging from 2.13 to 6.07. Besides, compounds (Z)-3-((3-(3,5-dimethoxyphenyl)-1H-pyrazol-5-yl)methyl)-5-(quinolin-4ylmeth-ylene)thiazolidine-2,4-dione (7e), (Z)-3-((3-(4-chlorophenyl)-1H-pyrazol-5-yl)methyl)-5-(quinolin-4-ylmethylene)thiazolidine-2,4- dione (7h), (Z)-4-(5-((2,4-dioxo-5-(quinolin-4-ylmeth- ylene)thiazolidin-3-yl)methyl)-1H-pyrazol-3-yl)benzonitrile (7i) and (Z)-3-((3-(4-nitrophenyl)-1H-pyrazol-5-yl)methyl)-5-(quino-lin-4-ylmethylene)thiazolidine-2,4-dione (7j) showed most promising potency against MCF-7 with IC_(50) values 5.97-6.43 μg/ mL. The ability of compounds 7d, 7e, 7h, 7i, 7j and 7m to inhibit EGFR tyrosine kinase was also studied and found that compounds 7d and 7m showed remarkable potency as compared to erlotinib with inhibition 87.6% and 91.4% respectively. Molecular docking studies were then carried out for most potent compounds 7d, 7i, and 7m and erlotinib on EGFR, and these compounds had encouraging binding energies and inhibition constants in comparison to erlotinib. Finally, compounds 7d, 7i and 7m have high intestinal absorption with Caco-2 permeability and followed Lipinski rules without any deviation.
机译:的合成一些新的quinoline-thiazolidine-2 4-dione耦合摘要本文通过Knoevengal凝结(7 a-7n),N-alkynylation和串联锅Sonogashiracoupling-cyclo-condensation路径。所有的化合物都进一步评估他们在体外anti-breast癌症活动对mda - mb - 231和MCF-7和结果与标准药物相比,埃罗替尼。类似物对MCF-7比是有效的mda - mb - 231。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号